HDAC9 and pulmonary arterial hypertension: The HDAC inhibitor SAHA can improve PAH by restoring histone acetylation, inducing Treg transformation, and regulating immune-vascular interaction-related genes such as PD-1 and BMPR-2 (Chen et al., 2023).